CALIGARIS CAPPIO, FEDERICO
 Distribuzione geografica
Continente #
EU - Europa 170
NA - Nord America 141
AS - Asia 78
SA - Sud America 1
Totale 390
Nazione #
US - Stati Uniti d'America 140
SE - Svezia 105
CN - Cina 43
SG - Singapore 30
IT - Italia 27
RU - Federazione Russa 17
FI - Finlandia 6
FR - Francia 3
IE - Irlanda 3
AE - Emirati Arabi Uniti 2
DE - Germania 2
ES - Italia 2
HU - Ungheria 2
AR - Argentina 1
CA - Canada 1
DK - Danimarca 1
IL - Israele 1
IN - India 1
KZ - Kazakistan 1
NL - Olanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 390
Città #
Lawrence 23
Princeton 23
Singapore 23
Shanghai 21
Milan 20
New York 14
Ashburn 13
Helsinki 6
Moscow 6
Boardman 3
Dublin 3
Guangzhou 3
Barcelona 2
Dubai 2
Ferrara 2
Sopron 2
Wuxi 2
Almaty 1
Beijing 1
Bologna 1
Bratislava 1
Corrientes 1
Dallas 1
Genoa 1
Los Angeles 1
Missaglia 1
Munich 1
Naaldwijk 1
Newark 1
Pune 1
Shenzhen 1
Tel Aviv 1
Xi'an 1
Totale 184
Nome #
Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment 24
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia 23
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 23
Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens 21
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 20
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 20
Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia 19
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 19
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 19
Monoclonal B-cell lymphocytosis: right track or red herring? 18
Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models 17
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia 17
Targeting B-cell anergy in chronic lymphocytic leukemia. 16
Distinct Innate Immunity Pathways to Activation and Tolerance in Subgroups of Chronic Lymphocytic Leukemia with Distinct Immunoglobulin Receptors. 16
In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors 16
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis 16
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 16
General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. 15
Leukemic blasts secondary to myelodysplastic syndromes are molecularly programmed to differentiate into functionally mature dendritic cells 14
Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors. 14
Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions. 14
The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia. 13
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients 12
Totale 402
Categoria #
all - tutte 6.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 13 1 0 0 3 2 0 0 0
2022/2023152 54 44 11 0 1 20 2 9 11 0 0 0
2023/2024126 7 15 14 26 11 16 3 15 0 2 5 12
2024/202581 38 3 2 20 18 0 0 0 0 0 0 0
Totale 402